Spyre Therapeutics (SYRE) Non-Current Assets (2015 - 2025)
Spyre Therapeutics (SYRE) recorded Non-Current Assets of $10,000 in Q1 2025, down 97.0% from $329,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Spyre Therapeutics (SYRE) Non-Current Assets (2015 - 2025) Analysis & Trends
Starting with Q4 2015, Spyre Therapeutics' Non-Current Assets history includes 38 quarters.
- Annual Non-Current Assets has declined for four straight years, with a five-year compound annual growth rate of -74.2% (FY2019 to FY2024).
- Across earlier years, Non-Current Assets came in at $331,000 in FY2023 (-96.3%), $8.89 million in FY2022 (-19.5%), $11.04 million in FY2021 (-6.7%) and $11.83 million in FY2020 (+36.3%).
- Quarterly Non-Current Assets has ranged from $10,000 in Q3 2024 to $12.61 million in Q2 2021 over the past five years.
- On a year-over-year basis, Non-Current Assets has declined for 14 consecutive quarters, with an average decline of 90.8% over the last eight quarters.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 50.4% in Q3 2020, against a decline of 99.2% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $10,000 (Q4 2024), $10,000 (Q3 2024) and $331,000 (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Spyre Therapeutics | 7.46 Bn | 7.46 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | 10,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Jun 30, 2024 | 331,000.00 |
| Mar 31, 2024 | 329,000.00 |
| Dec 31, 2023 | 331,000.00 |
| Sep 30, 2023 | 1.32 Mn |
| Jun 30, 2023 | 3.64 Mn |
| Mar 31, 2023 | 8.08 Mn |
| Dec 31, 2022 | 8.89 Mn |
| Sep 30, 2022 | 9.35 Mn |
| Jun 30, 2022 | 10.06 Mn |
| Mar 31, 2022 | 10.57 Mn |
| Dec 31, 2021 | 11.04 Mn |
| Sep 30, 2021 | 11.55 Mn |
| Jun 30, 2021 | 12.61 Mn |
| Mar 31, 2021 | 12.20 Mn |
| Dec 31, 2020 | 11.83 Mn |
| Sep 30, 2020 | 11.23 Mn |
| Jun 30, 2020 | 11.05 Mn |
API Access
Spyre Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=SYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "SYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=SYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();